Generated by Llama 3.3-70B| Stomach cancer | |
|---|---|
| Name | Stomach cancer |
| Diseasesdb | 12445 |
| Icd10 | C16 |
| Icd9 | 151 |
Stomach cancer, also known as Gastric cancer, is a type of Cancer that affects the Stomach, which is a vital part of the Digestive system and plays a crucial role in the Metabolism of Food and Drugs. According to the National Cancer Institute and the American Cancer Society, Stomach cancer is a leading cause of Cancer deaths worldwide, with a high incidence in countries such as Japan, China, and Korea. The World Health Organization and the International Agency for Research on Cancer have conducted extensive research on the disease, which has been supported by organizations such as the National Institutes of Health and the European Organization for Research and Treatment of Cancer.
Stomach cancer is defined as a malignant tumor that arises from the lining of the Stomach, which is composed of Epithelial cells and Glandular cells. The exact causes of Stomach cancer are not fully understood, but it is believed to be related to a combination of Genetic mutations and Environmental factors, such as Infection with Helicobacter pylori, a type of Bacteria that can cause Gastritis and Peptic ulcer disease. Other risk factors include a diet high in Salt and Smoking, which can increase the risk of developing Cancer of the Stomach, as reported by the Centers for Disease Control and Prevention and the Food and Drug Administration. Researchers at Harvard University and the University of California, Los Angeles have also identified Genetic predisposition as a significant risk factor, particularly in families with a history of Cancer.
The symptoms of Stomach cancer can be non-specific and may include Abdominal pain, Nausea, Vomiting, and Weight loss, which can be similar to those experienced by patients with Gastroesophageal reflux disease and Peptic ulcer disease. Diagnosis is typically made using a combination of Endoscopy, Biopsy, and Imaging studies such as Computed tomography and Magnetic resonance imaging, which are commonly used at hospitals such as Massachusetts General Hospital and Memorial Sloan Kettering Cancer Center. The American College of Gastroenterology and the American Gastroenterological Association have established guidelines for the diagnosis and management of Stomach cancer, which have been supported by organizations such as the National Comprehensive Cancer Network and the European Society for Medical Oncology.
There are several types of Stomach cancer, including Adenocarcinoma, Lymphoma, and Gastrointestinal stromal tumor, which can be classified using the Tumor, Node, Metastasis system developed by the American Joint Committee on Cancer. The staging of Stomach cancer is critical for determining the prognosis and treatment plan, which can involve Surgery, Chemotherapy, and Radiation therapy, as reported by the Journal of Clinical Oncology and the New England Journal of Medicine. Researchers at Stanford University and the University of Texas MD Anderson Cancer Center have also developed new staging systems, such as the Japanese Classification of Gastric Carcinoma, which have been adopted by organizations such as the International Gastric Cancer Association and the European Society of Surgical Oncology.
The treatment of Stomach cancer depends on the stage and type of cancer, as well as the overall health of the patient, which can be evaluated using the Eastern Cooperative Oncology Group performance status. Surgery is often the primary treatment for early-stage Stomach cancer, which can be performed at hospitals such as Johns Hopkins Hospital and University of California, San Francisco. Chemotherapy and Radiation therapy may also be used to treat advanced Stomach cancer, which can be administered at cancer centers such as the Dana-Farber Cancer Institute and the University of Chicago Medicine. The National Cancer Institute and the American Cancer Society have also developed guidelines for the treatment of Stomach cancer, which have been supported by organizations such as the American Society of Clinical Oncology and the European Society for Medical Oncology.
Stomach cancer is a significant public health problem worldwide, with a high incidence in countries such as Japan, China, and Korea, as reported by the World Health Organization and the International Agency for Research on Cancer. The risk factors for Stomach cancer include Infection with Helicobacter pylori, a diet high in Salt and Smoking, which can increase the risk of developing Cancer of the Stomach. Researchers at Harvard University and the University of California, Los Angeles have also identified Genetic predisposition as a significant risk factor, particularly in families with a history of Cancer. The Centers for Disease Control and Prevention and the Food and Drug Administration have also developed programs to reduce the risk of Stomach cancer, which have been supported by organizations such as the National Institutes of Health and the European Organization for Research and Treatment of Cancer.
The prognosis for Stomach cancer depends on the stage and type of cancer, as well as the overall health of the patient, which can be evaluated using the Eastern Cooperative Oncology Group performance status. The 5-year survival rate for Stomach cancer is approximately 30%, according to the National Cancer Institute and the American Cancer Society. However, with early detection and treatment, the prognosis can be improved, as reported by the Journal of Clinical Oncology and the New England Journal of Medicine. Researchers at Stanford University and the University of Texas MD Anderson Cancer Center have also developed new treatments, such as Immunotherapy and Targeted therapy, which have shown promising results in clinical trials, as reported by the Lancet and the Journal of the American Medical Association. The International Gastric Cancer Association and the European Society of Surgical Oncology have also developed guidelines for the management of Stomach cancer, which have been supported by organizations such as the American Society of Clinical Oncology and the European Society for Medical Oncology. Category:Cancer